All Things Mobile Analytic Inc., OTC: ATMH is a full service FINTECH innovative technology company focused on providing technology for micropayments and mobile device online gaming, telecommunications etc. The Company’s innovative line of custom applications such as PayToGo and E-Money Apps bridge the gap between financial and essential services for consumers globally.
The total immuno-oncology market will be worth approximately $14 billion by 2019, rising to $34 billion by 2024, as the treatment of cancer patients undergoes drastic changes over the next decade, according to researchers.
Biotech StocksCompany Profiles
According to the latest news from the company, Roswell Park now has FDA authorization to proceed with its Phase 2 study investigating the effectiveness and safety of aspirin and Ampligen with or without interferon-alpha 2b (Intron A) compared to no drug treatments in a randomized three-arm study of patients with prostate cancer before undergoing radical prostatectomy.